Minimed Group (STU:B8S) Short-Term Debt: €117 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:B8S Minimed Group Inc STU:B8S
20 GF Score
Price €16.60
! 3 Warning Signs
View Full Analysis

What is Minimed Group Short-Term Debt?

Minimed Group STU:B8S 20 Short-Term Debt is €117 Mil as of Apr. 2026. GuruFocus rates STU:B8S with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Minimed Group's Short-Term Debt for the quarter that ended in Apr. 2026 was €117 Mil.

Minimed Group's quarterly Short-Term Debt stayed the same from Oct. 2025 (€0 Mil) to Jan. 2026 (€0 Mil) but then increased from Jan. 2026 (€0 Mil) to Apr. 2026 (€117 Mil).

Minimed Group's annual Short-Term Debt stayed the same from Apr. 2024 (€0 Mil) to Apr. 2025 (€0 Mil) but then increased from Apr. 2025 (€0 Mil) to Apr. 2026 (€117 Mil).

Minimed Group Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Minimed Group Short-Term Debt Related Terms

Minimed Group Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Minimed Group's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Short-Term Debt Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Short-Term Debt
0.00 0.00 0.00 117.14

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26 Apr26
Short-Term Debt Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 117.14
STU:B8S
20GF Score
Minimed Group Inc STU:B8S
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €117 Mil mean?
Minimed Group (STU:B8S) has a Short-Term Debt of €117 Mil as of Apr. 2026.
Is Minimed Group's Short-Term Debt too high?
Minimed Group's current Short-Term Debt is €117 Mil. Overall, Minimed Group has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Short-Term Debt compare to MMSI and NVST?
Minimed Group's Short-Term Debt of €117 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Minimed Group's current Short-Term Debt is €117 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (STU:B8S) has a current Short-Term Debt of €117 Mil. The current Short-Term Debt is €117 Mil. Minimed Group's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Minimed Group (STU:B8S), the current Short-Term Debt is €117 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges MMED:USA
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
20GF Score

Get the complete analysis for STU:B8S

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.60
Price